I-O Clinical Trials Update

To obtain the latest editions of EMC’s Immuno-Oncology Clinical Trials Update, please complete this form.


* Required



I-O CLINICAL TRIALS UPDATE is a MONTHLY review of clinical trials in the rapidly evolving IMMUNO-ONCOLOGY (I-O) MARKET.
On a regular basis, this service will look at the one of following areas of the I-O market, allowing each to be covered and updated around twice a year:
  • CAR cells (Jul 2017)
  • Bispecific antibodies (Aug 2017)
  • Checkpoint inhibitors: anti-PD-1/PD-L1 (Nov 2017)
  • Checkpoint inhibitors: others (Jan 2017)
  • Oncolytic viruses (Feb 2017)
  • ADCs (antibody-drug conjugates) (Mar 2017)
  • Therapeutic vaccines (Apr 2017)
  • Immune activators and co-stimulators (Jun 2017)
Through this complimentary service you will be able to build up a detailed database of the hundreds of clinical trials in this exploding and highly competitive market.
 Please give us feedback on the value of this service at info@emcanalytics.com.